4D Molecular Therapeutics, Inc.
USD11.38
+0.28 (+2.57%)
CEO
David H. Kirn
IPO Date
2020-12-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$11.11
Prev. Close
$11.09
Day Low
$11.01
Day High
$11.96
52W Low
$4.21
52W High
$14.00
Market Cap
$0.59B
Volume
0.99M
| 15,283 |
| $12.01 |
| 14 Jul 2026 | Kirn David | director, officer: See Remarks | S-Sale | Disposed | 442 | $12.84 |
| 2 Jul 2026 | Bizily Scott | Chief Legal Officer | M-Exempt | Acquired | 814 | $4.14 |
| 2 Jul 2026 | Bizily Scott | Chief Legal Officer | M-Exempt | Acquired | 5,752 | $6.49 |
| 2 Jul 2026 | Bizily Scott | Chief Legal Officer | S-Sale | Disposed | 6,566 | $14.00 |
| 2 Jul 2026 | Bizily Scott | Chief Legal Officer | M-Exempt | Disposed | 814 | $4.14 |
| 2 Jul 2026 | Bizily Scott | Chief Legal Officer | M-Exempt | Disposed | 5,752 | $6.49 |
| 25 Jun 2026 | Bizily Scott | Chief Legal Officer | M-Exempt | Acquired | 9,810 | $4.14 |
| 25 Jun 2026 | Bizily Scott | Chief Legal Officer | S-Sale | Disposed | 9,810 | $12.00 |